These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 17412809)

  • 1. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
    Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
    Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations.
    Bryan PM; Xu X; Dickey DM; Chen Y; Potter LR
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1636-44. PubMed ID: 17264312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
    Crook RB; Chang AT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization.
    Potter LR
    Biochemistry; 1998 Feb; 37(8):2422-9. PubMed ID: 9485390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
    Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
    J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta.
    Drewett JG; Fendly BM; Garbers DL; Lowe DG
    J Biol Chem; 1995 Mar; 270(9):4668-74. PubMed ID: 7876238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
    Thibault G; Grove KL; Deschepper CF
    Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.
    Dickey DM; Dries DL; Margulies KB; Potter LR
    J Mol Cell Cardiol; 2012 Mar; 52(3):727-32. PubMed ID: 22133375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea.
    Kim SZ; Kim HS; Lee KS; Lee SJ; Seul KH; Koh GY; Cho KW; Kim SH
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2671-7. PubMed ID: 10937581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
    Sellitti DF; Puggina E; Lagranha C; Doi SQ
    J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.
    Savoie P; de Champlain J; Anand-Srivastava MB
    FEBS Lett; 1995 Aug; 370(1-2):6-10. PubMed ID: 7649305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.
    Potter LR
    Pharmacol Ther; 2011 Apr; 130(1):71-82. PubMed ID: 21185863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptide receptor-C signaling and regulation.
    Anand-Srivastava MB
    Peptides; 2005 Jun; 26(6):1044-59. PubMed ID: 15911072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine impairs the guanylyl cyclase activity of the natriuretic peptide receptor in the glomerulus.
    Kook H; Kim SW; Kang SY; Kim SZ; Kim JH; Choi KC; Lee J; Cho KW; Baik YH
    Pharmacol Res; 2000 Nov; 42(5):435-41. PubMed ID: 11023705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
    Abbey SE; Potter LR
    Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.
    Christoffersen C; Bartels ED; Nielsen LB
    Eur J Clin Invest; 2006 Feb; 36(2):69-75. PubMed ID: 16436087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natriuretic peptide system].
    Itoh H; Nakao K
    Nihon Rinsho; 1997 Aug; 55(8):1923-36. PubMed ID: 9284403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.